Israel Active

Healthcare organization Ballad Health, serving around a million people in 29 US counties, is adopting the AI-powered drug safety platform from Israel’s MedAware (see previously). The system identifies potential medication-related errors.

Bar-Ilan University graduate Aviv Mesika has developed the LacriScan diagnosis test which uses a patient’s tears to diagnose Alzheimer’s and Parkinson’s in their pre-symptom stages. The new test is more sensitive than previous ones and checks for multiple brain chemical markers of the two diseases.

Israel’s Actic Medical has developed the Hybrid+ insole. It has sensors that can measure the pressure, temperature, and motion of the foot to inform the wearer of impending foot ulcers. The patient then uses a special screwdriver to change the insole’s shape to redistribute the pressure.

The Sheba Pandemic Research Institute (SPRI) is partnering with the US National Institutes of Health (NIH) and others to develop a pan-coronavirus booster vaccine. The vaccine will also be applied to other viruses, including influenza, with the goal of preventing future pandemics.

Israel’s FertiliFit is developing a solution that uses AI-based technology to personalize IVF (and IUI) treatment to the specific patient.  Its deep learning model inputs the patient’s medical history, physiology, hormone levels etc., to identify the best treatment and the probability of success.

Researchers at Tel Aviv University encoded a toxin into mRNA (messenger RNA) molecules and delivered them directly to cancer cells. The cells were instructed to produce the toxin that eventually killed them. Another breakthrough from the lab of Professor Dan Peer.

This sounds like science fiction. 12-year-old Suleiman internally decapitated his head in a bicycle accident that detached the base of his skull from the top of his spine. Hadassah surgeons performed an extremely rare and complex operation to save Suleiman’s life.

Israel’s Escala Medical (see previously) has received €5.5 million from the European Innovation Council for its non-surgical, incision-free 20-minute solution for patients suffering pelvic prolapse. It also recently received US FDA clearance.

The 3D Optical Navigation System from Israel’s PathKeeper Surgical performed its debut commercial spine surgery on US patients. It was used in two successful lumbar spinal fusion surgeries for degenerative disc disease at VHC Health in Arlington, VA.

Israel’s VVT Medical has received US FDA approval for its Sclerosafe medical device for the treatment of varicose veins. Its unique, dual syringe injects a sclerosing substance into the vein through one syringe while simultaneously removing blood and residuals through the second syringe.